dcsimg 4th Annual Medical Device and Life Sciences Conference

4th Annual Medical Device and Life Sciences Conference

Innovation, Investing and Regulatory Issues

November 8, 2012

Renaissance Blackstone Chicago Hotel
636 South Michigan Avenue
Chicago, IL 60605

An interactive conference addressing key legal and business matters focusing on innovation, investing and regulatory issues in the medical device sector.

   
AGENDA  
   
8 – 8:30 a.m. Registration and Continental Breakfast
   
8:30 – 9 a.m. Welcome and Introductions
Senator Evan Bayh, Partner, McGuireWoods LLP
Kathleen Dooley, Partner, McGuireWoods LLP
Raj Natarajan, Partner, McGuireWoods LLP
   
9 – 9:45 a.m.
Chaos or Transformation – Healthcare 2013
Brian Scullion, M.D., Principal, William Blair & Company
Meghan Clune Woltman, Vice President, Government and Community Relations, Advocate Health Care
William Moffitt, President and Chief Executive Officer, Nanosphere Inc.
David Varhol, Managing Director, GE Healthcare Financial Services Inc.
Scott Becker, Partner, McGuireWoods LLP (Moderator)
   
  TRACK A – INVESTING AND FINANCE – DEVICES, DIAGNOSTICS AND LIFE SCIENCES
   
9:45 – 10:25 a.m. Medical Devices – The Next Four Years
Ross Gordon, Director, Lincoln International
Jay Istvan, Director, Bain & Company, Inc.
Geoffrey Cockrell, Partner, McGuireWoods LLP (Moderator)
   
10:30 – 11:10 a.m. Mergers and Acquisitions in the Medical Device and Diagnostics Sector, Pricing and Other Issues
Benjamin Daverman, Vice President, GTCR LLC
Brian Friedman, Managing Director, First Analysis Securities Corporation
Brian Scullion, Principal, William Blair & Company
Geoffrey Cockrell, Partner, McGuireWoods LLP (Moderator)
   
  TRACK B – SPECIALTY AREAS WITHIN DEVICES AND LIFE SCIENCES
   
9:45 – 10:25 a.m. Receiving Reimbursement for New Therapies and Other Patient Access Issues
Dee George, Associate Director, State Government Affairs, Dendreon Corporation
Jim Williams, Chief Operating Officer, Accelitech
Brad Alexander, Senior Vice President, McGuireWoods Consulting LLC
Stephanie Kennan, Senior Vice President, McGuireWoods Consulting LLC (Moderator)
   
10:30 – 11:10 a.m. Innovations and New Ideas and Applications in the Healthcare and Life Sciences Space
Michael Flavin, Chief Executive Officer, Shamrock Structures LLC
Barbara Goodman, Senior Vice President, PROPEL, iBIO Institute
Tom Hearn, Managing Principal, Novarus Healthcare, LLC
Jason Greis, Attorney, McGuireWoods LLP (Moderator)
   
  TRACK C – LEGAL AND GOVERNMENT AFFAIRS
   
9:45 – 10:25 a.m. The Device Sector Key Legal Issues
Susan Lichtenstein, Senior Vice President, Hill-Rom Holdings Inc.
Amy Manning, Partner, McGuireWoods LLP (Moderator)
   
10:30 – 11:10 a.m. FDA, Governmental Affairs and Compliance Issues
Shirell Gross, Director and Senior Counsel, Bayer HealthCare
Sally Maher, Vice President Clinical and Regulatory Affairs, Edwards Lifesciences
Jennie Orrico, Senior Counsel, Baxter, International Inc.
Melissa Gilmore, Attorney, McGuireWoods LLP
Christina Egan, Partner, McGuireWoods LLP (Moderator)
Helen Suh, Attorney, McGuireWoods LLP (Moderator)
   
11:10 – 11:20 a.m. Networking Break
   
  TRACK A – INVESTING AND FINANCE – DEVICES, DIAGNOSTICS AND LIFE SCIENCES
   
11:20 a.m. – Noon The Future of and Opportunities in the Pharma Industry – Trends and Issues
Jason Cohen, Senior Vice President, GE Capital
Dr. Erik Eglite, Vice President, Chief Compliance Officer and Corporate Counsel, Lundbeck, LLC
Laura Pearl, Managing Director, Ceres Venture Fund, L.P.
Brian Parker, Partner, McGuireWoods LLP
Amber Walsh, Partner, McGuireWoods LLP (Moderator)
   
  TRACK B – SPECIALTY AREAS WITHIN DEVICES AND LIFE SCIENCES
   
11:20 a.m. – Noon Orthopedic Implants and Technology Current Developments
John Cherf, M.D., Orthopedic Surgeon, The Chicago Institute of Orthopedics
Rob Collins, Chief Executive Officer, Suspension Orthopedics
Katherine Lin, Attorney, McGuireWoods LLP (Moderator)
   
  TRACK C – LEGAL AND GOVERNMENT AFFAIRS
   
11:20 a.m. – Noon False Claims, Sunshine Act, FCPA, Marketing and other Compliance Issues in the Device Sector
Kimberly Kannensohn, Partner, McGuireWoods LLP
David Pivnick, Attorney, McGuireWoods LLP
Jeffrey Rogers, Partner, McGuireWoods LLP
Scott Becker, Partner, McGuireWoods LLP (Moderator)
   
Noon – 1 p.m. Networking Lunch
   
  TRACK A – INVESTING AND FINANCE – DEVICES, DIAGNOSTICS AND LIFE SCIENCES
   
1 – 1:40 p.m. Investing in the Medical Device and Diagnostic Arena – Private Equity and Finance Perspective
David Anderson, Senior Vice President, GE Capital, Healthcare Financial Services
Josh Groman, PhD, Managing Director – Life Sciences, MidCap Financial, LLC
Faraaz Kamran, Group Head – Healthcare Leveraged Finance, Madison Capital Funding LLC
Dr. Andy Zamar, Consultant Psychiatrist, Auris Medical Europe Ltd.
Raj Natarajan, Partner, McGuireWoods LLP (Moderator)
   
1:45 – 2:25 p.m. Financing and Transaction Issues for the Medical Device and Diagnostic Industry
Michael Broderick, Director, Capital Source
Stephen Blumenreich, Investment Banker, Raymond James Financial Inc.
Melissa Gilmore, Attorney, McGuireWoods LLP
Cassmer Ward, Chief Executive Officer, Clear Advantage Collar Inc.
Richard Grant, Partner, McGuireWoods LLP (Moderator)
   
2:30 – 3:10 p.m. Acquisition and Sector Due Diligence in the Device and Life Sciences Sector
David Schlissel, Managing Director, Alvarez & Marsal Holdings LLC
Barry Straube, M.D., Director, The Marwood Group (formerly Chief Medical Officer, CMS)
Helen Suh, Attorney, McGuireWoods LLP
Richard Grant, Partner, McGuireWoods LLP (Moderator)
   
  TRACK B – SPECIALTY AREAS WITHIN DEVICES AND LIFE SCIENCES
   
1 – 1:40 p.m. Developments in the Spine Device and Implants Arena – A Physician’s Perspective
Frank Phillips, M.D., Midwest Orthopedics at Rush
   
1:45 – 2:25 p.m. Company Presentations
Itai Nemovicher, President and Chief Executive Officer, The Orthopaedic Implant Company
Rob Collins, Chief Executive Officer, Suspension Orthopaedic Solutions
Holly Carnell, Attorney, McGuireWoods LLP (Moderator)
   
2:30 – 3:10 p.m. Key Economic and Legal Issues in Prescription Drug Marketing
Richard Manning, Partner, Bates White Economic Consulting
   
  TRACK C – LEGAL AND GOVERNMENT AFFAIRS
   
1 – 1:40 p.m. Antitrust Issues in the Device and Life Sciences Sector
Amy Manning, Partner, McGuireWoods LLP
Angelo Russo, Partner, McGuireWoods LLP
   
1:45 – 2:25 p.m. Managing Risk for Life Sciences Companies – The Role of Insurance
Mark Lawless, Partner, McGuireWoods LLP
   
2:30 – 3:10 p.m. Emerging Litigation Issues in the Device and Life Sciences Sector
Jeffrey Clark, Partner, McGuireWoods LLP
Christina Egan, Partner, McGuireWoods LLP
Jonathan Maude, Partner, McGuireWoods LLP
James Schanaberger, Attorney, McGuireWoods LLP
David Pivnick, Attorney, McGuireWoods LLP (Moderator)
   
3:10 – 3:20 a.m. Networking Break
   
  TRACK A – INVESTING AND FINANCE – DEVICES, DIAGNOSTICS AND LIFE SCIENCES
   
3:20 – 4 p.m. Implications of a New Reimbursement Landscape for Device Manufacturers
Stephen Rothenberg, Consultant, Numerof & Associates
Kimberly White, Consultant, Numerof & Associates
   
4:05 – 4:45 p.m. Innovation, Regulation and Investment in the Device and Diagnostics Sectors
Michael Butler, President and Chief Executive Officer, Life Spine
   
4:50 – 5:30 p.m. Key Issues Raised by the AWP Cases and Reimbursement in the Post- AWP Era
Chris Stomberg, Ph.D., Partner, Bates White Economic Consulting
   
  TRACK B – SPECIALTY AREAS WITHIN DEVICES AND LIFE SCIENCES
   
3:20 – 4 p.m. Company Presentations
Dr. Andy Zamar, Consultant Psychiatrist, Auris MedTech Europe Ltd.
Cassmer Ward, Chief Executive Officer, Clear Advantage Collar Inc.
Mary DeBartolo, Attorney, McGuireWoods LLP (Moderator)
   
4:05 – 4:45 p.m. DOJ and FDA Investigations in Implantable Cardiac Defibrillators and other Developments in the Cardiovascular Space
Kevin Cornish, Managing Director, Navigant Consulting Inc.
   
4:50 – 5:30 p.m. Company Presentations
Kerwin Brandt, President and Chief Executive Officer, Accelitech
Michael Flavin, Chief Executive Officer, Shamrock Structures LLC
Drew McCormick, Attorney, McGuireWoods LLP (Moderator)
   
  TRACK C – LEGAL AND GOVERNMENT AFFAIRS
   
3:20 – 4 p.m. The Fair Market Value of Royalty Consulting Agreements in the Arena of Orthopedic Devices
Shawn Sentilles, Assistant General Counsel, Wright Medical Technology, Inc.
Edward Gold, Ph.D., Managing Director, Invotex Group
   
4:05 – 4:45 p.m. Monitoring Social Media & the Web to Handle Product Diversion, Off-Label Use, Adverse Events and Other Legal Issues
Shaleen Gupta, President, Semantelli Corporation
Kathleen Dooley, Partner, McGuireWoods LLP
   
4:50 – 5:30 p.m. Sunshine Laws Update and Planning for 2013
Sapan Singh, Senior Manager, Transparency at  Stryker
Jonathan Helm, AVA, Manager, VMG Health
Kimberly Kannensohn, Partner, McGuireWoods LLP
   
5:30 – 7 p.m. Networking Reception